Michael J Walters, MD | |
1101 26th St S, Great Falls, MT 59405 | |
(406) 455-5000 | |
(406) 731-8318 |
Full Name | Michael J Walters |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 30 Years |
Location | 1101 26th St S, Great Falls, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285728949 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | 9611 (Montana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Benefis Hospitals Inc | Great falls, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Benefis Hospitals Inc | 1153235296 | 279 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
› Verified 8 days ago
Entity Name | Radiology Montana Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497820559 PECOS PAC ID: 5597730267 Enrollment ID: O20040827000225 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
› Verified 8 days ago
Entity Name | Benefis Hospitals Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780968974 PECOS PAC ID: 1153235296 Enrollment ID: O20100629000044 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael J Walters, MD 1101 26th St S, Great Falls, MT 59405-5161 Ph: (406) 455-5000 | Michael J Walters, MD 1101 26th St S, Great Falls, MT 59405 Ph: (406) 455-5000 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.
IRIN reports on the Global Food Security Act, a bill aimed at expanding the U.S. government's role in combatting hunger around the world. The legislation is co-sponsored by Sens. Richard Lugar (R-Ind.) and Bob Casey (D-Pa.).
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
› Verified 8 days ago
Dr. Andrew Clawson Baugh, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave S Ste 204, Great Falls, MT 59405 Phone: 406-727-0484 Fax: 406-453-9504 | |
Anastasia Marie Balius, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5000 | |
Ronald T. Egan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5 Bob Marshall Pl, Great Falls, MT 59404 Phone: 406-727-5939 Fax: 406-727-5939 | |
Barbara Gutschenritter, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1117 29th St S, Great Falls, MT 59405 Phone: 406-731-8240 Fax: 406-731-8289 | |
Dr. Kelly Jane Underhill, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 15th Ave S, Great Falls, MT 59405 Phone: 406-454-2171 | |
Gary L. Schumacher, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5665 |